Bader Almuzzaini

7PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsMolecular targetsHaematological tumoursCancer geneticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 05, 2023
Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP).

Maha Al Ammari, Bader Almuzzaini, Khalid Al Sulaiman

|May 05, 2022
Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling.

Sabine Matou-Nasri, Maria Najdi, Nouran Abu AlSaud

|Sep 28, 2021
Identification of CSF3R Mutations in B-Lineage Acute Lymphoblastic Leukemia Using Comprehensive Cancer Panel and Next-Generation Sequencing.

Mamoon Rashid, Abdulrahman Alasiri, Mohammad A Al Balwi

|Jul 02, 2021
Identification of Novel Mutations in Colorectal Cancer Patients Using AmpliSeq Comprehensive Cancer Panel.

Bader Almuzzaini, Jahad Alghamdi, Alhanouf Alomani

|Mar 06, 2021
Pancytopenia, Recurrent Infection, Poor Wound Healing, Heterotopia of the Brain Probably Associated with A Candidate Novel de Novo CDC42 Gene Defect: Expanding the Molecular and Phenotypic Spectrum.

Abdulaziz Asiri, Deemah Alwadaani, Muhammad Umair

|Jul 17, 2020
The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort.

Maha Al Ammari, Mohammed AlBalwi, Khizra Sultana

Pageof 2

Frequent Collaborators

4 joint publications

Mohammed AlBalwi

3 joint publications

Jahad Alghamdi

1 joint publications

Abdulaziz Asiri

1 joint publications

Muhammad Umair